Search results
Spero Therapeutics, Inc. (SPRO) Loses -9.78% in 4 Weeks, Here's Why a Trend Reversal May be Around...
Zacks via Yahoo Finance· 1 year agoSpero Therapeutics, Inc. (SPRO) has become technically an oversold stock now, which implies...
Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK
Zacks via Yahoo Finance· 2 years agoShares of Spero Therapeutics SPRO surged 168% after it announced an exclusive license agreement with...
Shareholders in Spero Therapeutics (NASDAQ:SPRO) are in the red if they invested three years ago
Simply Wall St. via Yahoo Finance· 3 days agoSpero Therapeutics, Inc. (NASDAQ:SPRO) shareholders should be happy to see the share price up 23% in...
Spero Therapeutics, Inc. (SPRO) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 2 years agoSpero Therapeutics, Inc. (SPRO) possesses the right combination of the two key ingredients for a...
Spero Therapeutics (NASDAQ:SPRO) adds US$10m to market cap in the past 7 days, though investors from...
Simply Wall St. via Yahoo Finance· 1 year agoSpero Therapeutics, Inc. (NASDAQ:SPRO) shareholders should be happy to see the share price up 18% in...
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Stock's On An Uptrend: Are Strong Financials Guiding The...
Simply Wall St. via Yahoo Finance· 2 months agoMost readers would already be aware that Spero Therapeutics' (NASDAQ:SPRO) stock increased...
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoSpero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript March 13, 2024 Spero...
Spero Therapeutics, Inc.'s (NASDAQ:SPRO) Price Is Right But Growth Is Lacking After Shares Rocket...
Simply Wall St. via Yahoo Finance· 1 year agoSpero Therapeutics, Inc. (NASDAQ:SPRO) shareholders are no doubt pleased to see that the share price...
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoSpero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of -16.09% and 27.40%,...
Industry Analysts Just Upgraded Their Spero Therapeutics, Inc. (NASDAQ:SPRO) Revenue Forecasts By...
Simply Wall St. via Yahoo Finance· 1 year agoShareholders in Spero Therapeutics, Inc. (NASDAQ:SPRO) may be thrilled to learn that the analysts...